Related references
Note: Only part of the references are listed.Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding
Miao Gui et al.
CELL RESEARCH (2017)
Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset
Zhe Chen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Jesper Pallesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Ling Xu et al.
SCIENCE (2017)
Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains
Yuan Yuan et al.
NATURE COMMUNICATIONS (2017)
A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein (vol 6, e37, 2017)
Yingzhu Chen et al.
EMERGING MICROBES & INFECTIONS (2017)
A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential
Jiaqi Wang et al.
CELL (2017)
Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets
Neeltje van Doremalen et al.
ANTIVIRAL RESEARCH (2017)
Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection
Katherine V. Houser et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Pre-fusion structure of a human coronavirus spike protein
Robert N. Kirchdoerfer et al.
NATURE (2016)
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo
Thomas Luke et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012
Reed F. Johnson et al.
VIROLOGY (2016)
Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
Rosemarie D. Mason et al.
PLOS PATHOGENS (2016)
Animal models of Middle East respiratory syndrome coronavirus infection
Neeltje van Doremalen et al.
ANTIVIRAL RESEARCH (2015)
A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein
Yan Li et al.
CELL RESEARCH (2015)
Passive Immunotherapy with Dromedary Immune Serum in an Experimental Animal Model for Middle East Respiratory Syndrome Coronavirus Infection
Jincun Zhao et al.
JOURNAL OF VIROLOGY (2015)
Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease
Anurodh Shankar Agrawal et al.
JOURNAL OF VIROLOGY (2015)
Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus
Davide Corti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection
Kristen E. Pascal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody
Tianlei Ying et al.
NATURE COMMUNICATIONS (2015)
Evaluation of candidate vaccine approaches for MERS-CoV
Lingshu Wang et al.
NATURE COMMUNICATIONS (2015)
History of passive antibody administration for prevention and treatment of infectious diseases
Barney S. Graham et al.
CURRENT OPINION IN HIV AND AIDS (2015)
Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27
Xiaojuan Yu et al.
SCIENTIFIC REPORTS (2015)
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
Morgan S. A. Gilman et al.
PLOS PATHOGENS (2015)
Improving Neutralization Potency and Breadth by Combining Broadly Reactive HIV-1 Antibodies Targeting Major Neutralization Epitopes
Rui Kong et al.
JOURNAL OF VIROLOGY (2015)
Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control
Prasannavenkatesh Durai et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness
Jianhua Sui et al.
JOURNAL OF VIROLOGY (2014)
Exceptionally Potent Neutralization of Middle East Respiratory Syndrome Coronavirus by Human Monoclonal Antibodies
Tianlei Ying et al.
JOURNAL OF VIROLOGY (2014)
A Conformation-Dependent Neutralizing Monoclonal Antibody Specifically Targeting Receptor-Binding Domain in Middle East Respiratory Syndrome Coronavirus Spike Protein
Lanying Du et al.
JOURNAL OF VIROLOGY (2014)
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility
Simon Cauchemez et al.
LANCET INFECTIOUS DISEASES (2014)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution
Xian-Chun Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Potent Neutralization of MERS-CoV by Human Neutralizing Monoclonal Antibodies to the Viral Spike Glycoprotein
Liwei Jiang et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Human Infection with MERS Coronavirus after Exposure to Infected Camels, Saudi Arabia, 2013
Ziad A. Memish et al.
EMERGING INFECTIOUS DISEASES (2014)
How good are my data and what is the resolution?
Philip R. Evans et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4
Nianshuang Wang et al.
CELL RESEARCH (2013)
The Receptor Binding Domain of the New Middle East Respiratory Syndrome Coronavirus Maps to a 231-Residue Region in the Spike Protein That Efficiently Elicits Neutralizing Antibodies
Huihui Mou et al.
JOURNAL OF VIROLOGY (2013)
Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk
Romulus Breban et al.
LANCET (2013)
Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study
Abdullah Assiri et al.
LANCET INFECTIOUS DISEASES (2013)
Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26
Guangwen Lu et al.
NATURE (2013)
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia
Masashi Shingai et al.
NATURE (2013)
Hospital Outbreak of Middle East Respiratory Syndrome Coronavirus
Abdullah Assiri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Reverse genetics with a full-length infectious cDNA of the Middle East respiratory syndrome coronavirus
Trevor Scobey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells
Christopher Sundling et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Epitope Mapping of Broadly Neutralizing HIV-2 Human Monoclonal Antibodies
Rui Kong et al.
JOURNAL OF VIROLOGY (2012)
Structural and genetic basis for development of broadly neutralizing influenza antibodies
Daniel Lingwood et al.
NATURE (2012)
HIV therapy by a combination of broadly neutralizing antibodies in humanized mice
Florian Klein et al.
NATURE (2012)
Human Monoclonal Antibodies against Highly Conserved HR1 and HR2 Domains of the SARS-CoV Spike Protein Are More Broadly Neutralizing
Hatem A. Elshabrawy et al.
PLOS ONE (2012)
Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential
Melissa M. Coughlin et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Origin, diversity, and maturation of human antiviral antibodies analyzed by high-throughput sequencing
Ponraj Prabakaran et al.
Frontiers in Microbiology (2012)
iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM
T. Geoff G. Battye et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2011)
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
Xueling Wu et al.
SCIENCE (2011)
MolProbity: all-atom structure validation for macromolecular crystallography
Vincent B. Chen et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis
Xavier Brochet et al.
NUCLEIC ACIDS RESEARCH (2008)
Phaser crystallographic software
Airlie J. McCoy et al.
JOURNAL OF APPLIED CRYSTALLOGRAPHY (2007)
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
Andrew T. Catanzaro et al.
VACCINE (2007)
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates
DH Barouch et al.
JOURNAL OF VIROLOGY (2005)
Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses
ZY Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
CC Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Coot:: model-building tools for molecular graphics
P Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2004)
Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity
UJ Buchholz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
PHENIX:: building new software for automated crystallographic structure determination
PD Adams et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
Share Paper
